Vivus (VVUS) Spikes on Partnership Discussions
Tweet Send to a FriendGet Alerts VVUS Hot Sheet
Trade VVUS Now!
Vivus, Inc. (NASDAQ: VVUS) is active in mid-day trade on reports the CEO said the company has been having partnership talks with larger phrama companies on Qsymia and may reach a deal by year end.
A takeover is also said to be "inevitable."
After briefing spiking into positive territory, shares of VVUS are currently down 2.8 percent to $14.45.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
A takeover is also said to be "inevitable."
After briefing spiking into positive territory, shares of VVUS are currently down 2.8 percent to $14.45.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Lazard Capital Downgrades Vivus (VVUS) to Neutral
- Amid Tesla (TSLA) Squeeze, Option Prices Hit Record Highs
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
Create E-mail Alert Related Categories
Rumors, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
